ANTIEPILEPTIC ACTIVITY AND NEUROPHARMACOLOGICAL SCREENING OF METHANOLIC EXTRACT OF LEPTADENIA RETICULATA AGAINST DIFFERENT EXPERIMENTAL MODELS

Authors

  • Pushpa kumari.B*,Mahipal Reddy.R, Manasa Veena.B, Mohan babu.T, Ranganayakulu.D.

Keywords:

Leptadenia reticulata, antiepileptic activity, methanolic extract, neuropharmacology, maximal electroshock, pentylenetetrazol, status epilepticus, medicinal plants.

Abstract

Epilepsy is a chronic neurological disorder characterized by recurrent unprovoked seizures resulting from abnormal and excessive neuronal activity in the brain. Although several synthetic antiepileptic drugs are available, a considerable proportion of patients continue to experience inadequate seizure control or adverse effects, creating interest in plant-derived compounds with potential neuropharmacological activity. Leptadenia reticulata (Retz.) Wight & Arn., commonly known as Jivanti, is a medicinal plant traditionally used in South Asian systems of medicine and contains a variety of phytoconstituents including flavonoids, sterols, triterpenoids, phenolic compounds, and related secondary metabolites. The purpose of this study is to evaluate the reported antiepileptic potential and neuropharmacological profile of the methanolic extract of L. reticulata using established experimental models and to discuss possible mechanisms of action. A literature-based experimental analysis was conducted with emphasis on maximal electroshock, pentylenetetrazol, lithium–pilocarpine status epilepticus, and neurobehavioral screening approaches. Previous experimental work has reported that methanolic extract of L. reticulata demonstrated meaningful protection in maximal electroshock- and pentylenetetrazol-induced seizure models, whereas its activity was less pronounced in lithium–pilocarpine-induced status epilepticus [1,2]. These findings suggest that the extract may influence mechanisms associated with seizure propagation and inhibitory neurotransmission. The presence of flavonoids such as apigenin, rutin, luteolin-related compounds, and other bioactive constituents may contribute to these effects through antioxidant, neuroprotective, or neurotransmitter-modulating mechanisms. However, the currently available evidence remains primarily preclinical. Further studies are required to isolate active compounds, define molecular targets, establish dose–response relationships, and evaluate long-term safety before therapeutic conclusions can be drawn.

References

1. Pushpa KB, Mahipal RR, Manasa VB, Mohan BT, Ranganayakulu D. Antiepileptic activity and neuropharmacological screening of methanolic extract of Leptadenia reticulata against different experimental models. Journal of Advanced Drug Research. 2010;1:1–8.

2. Swamy MK, Sinniah UR, Ghasemzadeh A. Leptadenia reticulata (Retz.) Wight & Arn. (Jivanti): Botanical, agronomical, phytochemical, pharmacological, and biotechnological aspects. Molecules. 2017;22(6):1019. doi:10.3390/molecules22061019.

3. Kumari S, Saini R, Bhatnagar A, Mishra A. A comprehensive review on Ayurvedic herb Leptadenia reticulata (Jeevanti): A phytochemistry and pharmacological perspective. Natural Product Research. 2024;38(23):4234–4260. doi:10.1080/14786419.2023.2282119.

4. Patel RV, Patel VR, Patel MG. Phytochemical evaluation of dried aqueous extract of Jivanti [Leptadenia reticulata (Retz.) Wt. et Arn.]. Ayu. 2012;33:412–415.

5. Löscher W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure. 2011;20(5):359–368.

6. Löscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma. Epilepsia. 2011;52(4):657–678.

7. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nature Reviews Neuroscience. 2004;5:553–564.

8. Kandeda AK, Taiwe GS, Moto FCO, et al. Antiepileptogenic and neuroprotective effects of medicinal plant-derived compounds in experimental seizure models. Frontiers in Pharmacology. 2021.

9. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 5th ed. Oxford University Press; 2015.

10. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: A practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–482.

Downloads

Published

2010-02-10